Heterotopic ossification and severe COVID-19 infection.

Authors : Benkhaled S, Gomes da Silveira Cauduro C, Alexiou J, Jayankura M, Van Gestel D
Year : 2022
Journal : QJM
Volume : 115
Pages : 201-203

Antimicrobial susceptibility testing determined by Alfred 60/AST (Alifax®) in a multi-sites lab: performance's evaluation and optimization of workflow.

Authors : Cupaiolo R, Cherkaoui S, Serrano G, Dauby N, Georgala A, Blumental S, Maillart E, Hites M, Hallin M, Martiny D
Year : 2022
Journal : J Microbiol Methods
Volume : 194
Pages : 106433

Low-Dose Nivolumab with or without Ipilimumab as Adjuvant Therapy Following the Resection of Melanoma Metastases: A Sequential Dual Cohort Phase II Clinical Trial.

Authors : Schwarze JK, Garaud S, Jansen YJL, Awada G, Vandersleyen V, Tijtgat J, de Wind A, Kristanto P, Seremet T, Willard-Gallo K, Neyns B
Year : 2022
Journal : Cancers (Basel)
Volume : 14

Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrant.

Authors : Malorni L, Tyekucheva S, Hilbers FS, Ignatiadis M, Neven P, Colleoni M, Henry S, Ballestrero A, Bonetti A, Jerusalem G, Papadimitriou K, Bernardo A, Seles E, Duhoux FP, Macpherson IR, Thomson A, Davies DM, Bergqvist M, Migliaccio I, Gebhart G, Zoppoli G, Bliss JM, Benelli M, McCartney A, Kammler R, De Swert H, Ruepp B, Fumagalli D, Maibach R, Cameron D, Loi S, Piccart M, Regan MM
Year : 2022
Journal : Eur J Cancer
Volume : 164
Pages : 39-51

A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer.

Authors : Zhang Z, Xie S, Cai W, Hong ZN, Yang C, Lin Y, Zhu J, Lin Z, Christoph DC, Bohnenberger H, Kepka L, Brueckl WM, Van Houtte P, Kang M, Lin J
Year : 2022
Journal : Transl Lung Cancer Res
Volume : 11
Pages : 75-86

Code of practice needed for samples donated by trial participants.

Authors : Coleman R, Chan A, Barrios C, Cameron D, Costa L, Dowsett M, Harrison D, Howell A, Lacombe D, MacKenzie M, Martin M, McIntosh S, Morgan A, Piccart-Gebhart M, Spanic T
Year : 2022
Journal : Lancet Oncol
Volume : 23
Pages : e89-e90

Brentuximab Vedotin and Pembrolizumab Combination in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Single-Centre Retrospective Analysis.

Authors : Massaro F, Meuleman N, Bron D, Vercruyssen M, Maerevoet M
Year : 2022
Journal : Cancers (Basel)
Volume : 14

Fragility Fractures in Postmenopausal Women: Development of 5-Year Prediction Models Using the FRISBEE Study.

Authors : Baleanu F, Moreau M, Charles A, Iconaru L, Karmali R, Surquin M, Benoit F, Mugisha A, Paesmans M, Rubinstein M, Rozenberg S, Bergmann P, Body JJ
Year : 2022
Journal : J Clin Endocrinol Metab
Volume : 107
Pages : e2438-e2448

EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds.

Authors : Weber M, Lam M, Chiesa C, Konijnenberg M, Cremonesi M, Flamen P, Gnesin S, Bodei L, Kracmerova T, Luster M, Garin E, Herrmann K
Year : 2022
Journal : Eur J Nucl Med Mol Imaging
Volume : 49
Pages : 1682-1699

Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer.

Authors : Agostinetto E, Losurdo A, Nader-Marta G, Santoro A, Punie K, Barroso R, Popovic L, Solinas C, Kok M, de Azambuja E, Lambertini M
Year : 2022
Journal : Expert Opin Investig Drugs
Volume : 31
Pages : 567-591

The oxygen sensor prolyl hydroxylase domain 2 regulates the in vivo suppressive capacity of regulatory T cells.

Authors : Ajouaou Y, Azouz A, Taquin A, Denanglaire S, Hussein H, Krayem M, Andris F, Moser M, Goriely S, Leo O
Year : 2022
Journal : Elife
Volume : 11

ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group's perspective.

Authors : Koessler T, Alsina M, Arnold D, Ben-Aharon I, Collienne M, Lutz MP, Neuzillet C, Obermannova R, Peeters M, Sclafani F, Smyth E, Valle JW, Wagner AD, Wyrwicz L, Fontana E, Moehler M
Year : 2022
Journal : ESMO Open
Volume : 7
Pages : 100392

Evaluation of the Comprehensive Geriatric Assessment (CGA) tool as a predictor of postoperative complications following major oncological abdominal surgery in geriatric patients.

Authors : Penning Y, El Asmar A, Moreau M, Raspé J, Dal Lago L, Pepersack T, Donckier V, Liberale G
Year : 2022
Journal : PLoS One
Volume : 17
Pages : e0264790

Line-field confocal optical coherence tomography of basosquamous carcinoma: a case series with histopathological correlation.

Authors : Cappilli S, Cinotti E, Lenoir C, Tognetti L, Perez-Anker J, Rubegni P, Puig S, Malvehy J, Perrot JL, Del Marmol V, Peris K, Suppa M
Year : 2022
Journal : J Eur Acad Dermatol Venereol
Volume : 36
Pages : 1214-1218

The role of perilesional and multiparametric resonance imaging-targeted biopsies to reduce the risk of upgrading at radical prostatectomy pathology: A retrospective monocentric study.

Authors : Diamand R, Hollans M, Lefebvre Y, Sirtaine N, Limani K, Hawaux E, Abou Zahr R, Mattlet A, Albisinni S, Roumeguère T, Peltier A
Year : 2022
Journal : Urol Oncol
Volume : 40
Pages : 192.e11-192.e17

The 3^rd ESTRO-EFOMP core curriculum for medical physics experts in radiotherapy.

Authors : Garibaldi C, Essers M, Heijmen B, Bertholet J, Koutsouveli E, Schwarz M, Bert C, Bodale M, Casares-Magaz O, Gerskevitch E, Koniarova I, Korreman S, Lisbona A, Lopez Medina A, Maas A, Moeckli R, Moore M, Petrovic B, Piotrowski T, Poli E, Prezado Y, Reynaert N, Redalen KR, Stylianou Markidou E, Verellen D, Jornet N, Clark CH
Year : 2022
Journal : Radiother Oncol
Volume : 170
Pages : 89-94

The role of PSMA radioligands in the diagnosis and treatment of prostate carcinoma.

Authors : Rodríguez-Fraile M, Tamayo Alonso P, Rosales JJ, de Arcocha-Torres M, Caresia-Aróztegui AP, Cózar-Santiago MP, Orcajo-Rincon J, Simó Perdigó M, Delgado Bolton RC, Artigas C
Year : 2022
Journal : Rev Esp Med Nucl Imagen Mol (Engl Ed)
Volume : 41
Pages : 126-135

An Atypical Behavior of Metastatic Lung Disease in a Young Woman With Osteosarcoma: A Case Report.

Authors : Acquisto A, Duran Derijckere I, De Angelis R
Year : 2022
Journal : Cureus
Volume : 14
Pages : e21589

The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study.

Authors : Zijlstra JM, Follows G, Casasnovas RO, Vermaat JSP, Kalakonda N, Choquet S, Hill B, Thieblemont C, Cavallo F, Cruz F, Kuruvilla J, Hamad N, Jaeger U, Caimi P, Gurion R, Warzocha K, Bakhshi S, Sancho JM, Schuster M, Egyed M, Offner F, Vassilakopoulos TP, Samal P, Ku M, Xu J, Corona K, Chamoun K, Shah J, Canales M, Maerevoet M
Year : 2022
Journal : Cancers (Basel)
Volume : 14

Real-world effectiveness of palbociclib plus fulvestrant in advanced breast cancer: Results from a population-based cohort study.

Authors : Cardoso Borges F, Alves da Costa F, Ramos A, Ramos C, Bernardo C, Brito C, Mayer-da-Silva A, Furtado C, Ferreira AR, Martins-Branco D, Miranda A, Lourenço A
Year : 2022
Journal : Breast
Volume : 62
Pages : 135-143